Cemiplimab

Category: Cancer



Cemiplimab Overview

Cemiplimab, sold under the brand name Libtayo, is a monoclonal antibody medication for the treatment of squamous cell skin cancer.[5][6] Cemiplimab belongs to a class of drugs that binds to the programmed death receptor-1 (PD-1), blocking the PD-1/PD-L1 pathway.[4][7] The most common side effects include fatigue, rash, diarrhea, musculoskeletal pain, and nausea.[5][4] In September 2018, it was appr...

Read more Cemiplimab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cemiplimab

Recent Cemiplimab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cemiplimab
  • Injection: 350mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Cemiplimab or a similar ingredient: (1 result)